BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 32678342)

  • 1. A new dawn for eosinophils in the tumour microenvironment.
    Grisaru-Tal S; Itan M; Klion AD; Munitz A
    Nat Rev Cancer; 2020 Oct; 20(10):594-607. PubMed ID: 32678342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophils in the Tumor Microenvironment.
    Mattei F; Andreone S; Marone G; Gambardella AR; Loffredo S; Varricchi G; Schiavoni G
    Adv Exp Med Biol; 2020; 1273():1-28. PubMed ID: 33119873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophils in the tumor microenvironment: implications for cancer immunotherapy.
    Ghaffari S; Rezaei N
    J Transl Med; 2023 Aug; 21(1):551. PubMed ID: 37587450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of circRNAs in the tumour microenvironment.
    Zhang Q; Wang W; Zhou Q; Chen C; Yuan W; Liu J; Li X; Sun Z
    Mol Cancer; 2020 Jan; 19(1):14. PubMed ID: 31973726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated Eosinophils Exert Antitumorigenic Activities in Colorectal Cancer.
    Reichman H; Itan M; Rozenberg P; Yarmolovski T; Brazowski E; Varol C; Gluck N; Shapira S; Arber N; Qimron U; Karo-Atar D; Lee JJ; Munitz A
    Cancer Immunol Res; 2019 Mar; 7(3):388-400. PubMed ID: 30665890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The functions of autophagy at the tumour-immune interface.
    Luo X; Qiu Y; Dinesh P; Gong W; Jiang L; Feng X; Li J; Jiang Y; Lei YL; Chen Q
    J Cell Mol Med; 2021 Mar; 25(5):2333-2341. PubMed ID: 33605033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Tumor Necrosis Factor in Manipulating the Immunological Response of Tumor Microenvironment.
    Laha D; Grant R; Mishra P; Nilubol N
    Front Immunol; 2021; 12():656908. PubMed ID: 33986746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophils in Colorectal Cancer: Emerging Insights into Anti-Tumoral Mechanisms and Clinical Implications.
    Lopez-Perez D; Prados-Lopez B; Galvez J; Leon J; Carazo A
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local angiotensin II contributes to tumor resistance to checkpoint immunotherapy.
    Xie G; Cheng T; Lin J; Zhang L; Zheng J; Liu Y; Xie G; Wang B; Yuan Y
    J Immunother Cancer; 2018 Sep; 6(1):88. PubMed ID: 30208943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour microenvironment (TME) characterization identified prognosis and immunotherapy response in muscle-invasive bladder cancer (MIBC).
    Cao R; Yuan L; Ma B; Wang G; Tian Y
    Cancer Immunol Immunother; 2021 Jan; 70(1):1-18. PubMed ID: 32617668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNAs in the tumour microenvironment.
    Ma Z; Shuai Y; Gao X; Wen X; Ji J
    Mol Cancer; 2020 Jan; 19(1):8. PubMed ID: 31937318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactate in the tumour microenvironment: From immune modulation to therapy.
    Wang ZH; Peng WB; Zhang P; Yang XP; Zhou Q
    EBioMedicine; 2021 Nov; 73():103627. PubMed ID: 34656878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary tumors from mucosal barrier organs drive unique eosinophil infiltration patterns and clinical associations.
    Grisaru-Tal S; Itan M; Grass DG; Torres-Roca J; Eschrich SA; Gordon Y; Dolitzky A; Hazut I; Avlas S; Jacobsen EA; Ziv-Baran T; Munitz A
    Oncoimmunology; 2020 Dec; 10(1):1859732. PubMed ID: 33457078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research progress on eosinophils in lung cancer].
    Wei YQ; Lyu LH; Li M
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Nov; 57(11):1895-1900. PubMed ID: 38008583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of MIF on Eosinophil Biology and Eosinophilic Inflammation.
    Bozza MT; Lintomen L; Kitoko JZ; Paiva CN; Olsen PC
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):15-24. PubMed ID: 30680604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophils and cancer.
    Davis BP; Rothenberg ME
    Cancer Immunol Res; 2014 Jan; 2(1):1-8. PubMed ID: 24778159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR3 expression and activation of eosinophils: role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gamma.
    Jinquan T; Jing C; Jacobi HH; Reimert CM; Millner A; Quan S; Hansen JB; Dissing S; Malling HJ; Skov PS; Poulsen LK
    J Immunol; 2000 Aug; 165(3):1548-56. PubMed ID: 10903763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade.
    Chon HJ; Lee WS; Yang H; Kong SJ; Lee NK; Moon ES; Choi J; Han EC; Kim JH; Ahn JB; Kim JH; Kim C
    Clin Cancer Res; 2019 Mar; 25(5):1612-1623. PubMed ID: 30538109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocyte heterogeneity and functions in cancer.
    Olingy CE; Dinh HQ; Hedrick CC
    J Leukoc Biol; 2019 Aug; 106(2):309-322. PubMed ID: 30776148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes from eosinophils autoregulate and promote eosinophil functions.
    Cañas JA; Sastre B; Mazzeo C; Fernández-Nieto M; Rodrigo-Muñoz JM; González-Guerra A; Izquierdo M; Barranco P; Quirce S; Sastre J; Del Pozo V
    J Leukoc Biol; 2017 May; 101(5):1191-1199. PubMed ID: 28096299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.